Clinical Trial Update: Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating safety and preliminary efficacy of Imprime PGG in combination with cetuximab in patients with recurrent or progressive colorectal c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Imprime PGG

Snippet

Sponsor: HiberCell, Inc. | Conditions: Recurrent Colorectal Carcinoma, Progressive Colorectal Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-03-19